Acute Viral Bronchiolitis: To Treat or Not to Treat-That Is the Question

Journal of Pediatrics

Volumn 151, Issue 3, 2007, Pages 235-237

  Calogero, Claudia ^a   Sly, Peter D ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; IPRATROPIUM BROMIDE; SALBUTAMOL; SODIUM CHLORIDE; STEROID; TERBUTALINE;

AGE DISTRIBUTION; ASTHMA; CHILD; CYSTIC FIBROSIS; EDITORIAL; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LUNG FUNCTION; NEBULIZATION; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RHINOVIRUS; VIRAL BRONCHIOLITIS; WHEEZING;

ACUTE DISEASE; ADRENERGIC BETA-ANTAGONISTS; BRONCHIOLITIS, VIRAL; BRONCHODILATOR AGENTS; CHILD; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; HUMANS; LENGTH OF STAY; SALINE SOLUTION, HYPERTONIC;

EID: 34548142997     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2007.05.041     Document Type: Editorial

References (36)

1. Sly P.D., and Collins R.A. Physiological basis of respiratory signs and symptoms. Paediatr Respir Rev 7 (2006) 84-88
2. Everard M.L. Acute viral bronchiolitis and pneumonia in infancy resulting from the respiratory syncytial virus. In: Taussig L.M., Landau L.I., Le Souef P.N., Morgan W.J., Martinez F.D., and Sly P.D. (Eds). Pediatric respiratory medicine (1999), Mosby, St. Louis 580-595
3. Henderson F.W., Clyde W.J., and Collier A.M. The etiologic and epidemiologic spectrum of bronchiolitis in pediatric practice. J Pediatr 95 (1979) 183-190
4. Kim H., Arrobio J., and Brandt C. Epidemiology of respiratory syncytial virus infection in Washington, DC, importance of the virus in different disease syndromes and temporal distribution of infection. Am J Epidemiol 98 (1973) 216-225
5. Abzug M., Beam A., Gyorkos E., and Levin M. Viral pneumonia in the first of month of life. Pediatr Infect Dis J 9 (1990) 881-885
6. Sly P.D., and Hibbert M.E. Childhood asthma following hospitalization with acute viral bronchiolitis in infancy. Pediatr Pulmonol 7 (1989) 153-158
7. Stein R.T., Sherrill D., Morgan W.J., Holberg C.J., Halonen M., Taussig L.M., et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 354 (1999) 541-545
8. Pullan C.R., and Hey E.N. Wheezing, asthma and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. Br Med J 284 (1982) 1665-1669
9. Welliver R.C., and Duffy L. The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing, and pulmonary function at age 7-8 years. Pediatr Pulmonol 15 (1993) 19-27
10. Kusel M.M.H., de Klerk N.H., Holt P.G., Kebadze T., Johnston S.L., and Sly P.D. Role of respiratory viruses in acute upper and lower respiratory tract illness in the first year of life a birth cohort study. Pediatr Infect Dis J 25 (2006) 680-686
11. Lemanske R.F., Jackson D.J., Gangnon R.E., Evans M.D., Li Z., Shult P.A., et al. Rhinovirus illness during infancy predicts subsequent childhood wheezing. J Allergy Clin Immunol 116 (2005) 571-577
12. Young S., O'Keeffe P.T., Arnott J., and Landau L.I. Lung function, airway responsiveness, and respiratory symptoms before and after bronchiolitis. Arch Dis Child 72 (1995) 16-24
13. Martinez F.D., Wright A.L., Taussig L.M., Holberg C.J., Halonen M., and Morgan W.J. Asthma and wheezing in the first six years of life. N Eng J Med 332 (1995) 133-138
14. Macaubas C., de Klerk N., Holt B.J., Wee C., Kendall G., Firth M., et al. Association between antenatal cytokine production and the development of atopy and asthma at age 6 years. Lancet 362 (2003) 1192-1197
15. Rowe J., Macaubas C., Monger T., Holt B.J., Harvey J., Poolman J.T., et al. Heterogeneity in diptheria-tetanus-acellular pertussis vaccine-specific cellular immunity during infancy: relationship to variations in the kinetics of postnatal maturation of systematic Th1 function. J Infect Dis 184 (2001) 80-88
16. Stang P., Brandenburg N., and Carter B. The economic burden of respiratory syncytial virus-associated bronchiolitis hospitalizations. Arch Ped Adolesc Med 155 (2001) 95-96
17. Mullins J.A., Lamonte A.C., Bresee J.S., and Anderson L.J. Substantial variability in community respiratory syncytial virus season timing. Pediatr Infect Dis J 22 (2003) 857-886
18. Leader S., and Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997-2000. J Pediatr 143 (2003) S127-S132
19. Soto M.E., Sly P.D., Uren E., Taussig L.M., and Landau L.I. Bronchodilator response during acute viral bronchiolitis in infancy. Pediatr Pulmonol 2 (1985) 85-90
20. Hughes D.M., LeSouef P.N., and Landau L.I. Effect of salbutamol on respiratory mechanics in bronchiolitis. Pediatr Res 22 (1987) 83-88
21. O'Callaghan C., Milner A.D., and Swarbnick A. Paradoxical deterioration in lung function after nebulised salbutamol in wheezy infants. Lancet 2 (1988) 1424-1425
22. Prendiville A., Green A., and Silverman M. Paradoxical response to nebulised salbutamol, assessed by partial expiratory flow volume curves. Thorax 42 (1987) 81-91
23. Mallol J., Hibbert M.E., Robertson C.F., Olinsky A., Phelan P.D., and Sly P.D. Inherent variability of pulmonary function tests in infants with bronchiolitis. Pediatr Pulmonol 5 (1988) 152-157
24. Ho L., Collis G., Landau L.I., and LeSouef P.N. Effects of salbutamol on oxygen saturation in bronchiolitis. Arch Dis Child 60 (1991) 1061-1064
25. Mallol J., Barrueto L., Girardi G., Munoz R., Puppo H., Ulloa V., et al. Use of nebulised bronchodilators in infants under 1 year of age: analysis of four forms of therapy. Pediatr Pulmonol 3 (1987) 298-303
26. Wainwright C., Altimirano L., Cheney M., Cheney J., Barber S., Price D., et al. A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis. N Eng J Med 349 (2003) 27-35
27. Gadomski A.M., and Bhasale A.L. Bronchodilators for bronchiolitis. Cochrane Database of Systematic Reviews (2006) issue 3. Art No: CD001266. DOI: DOI: 10.1002/14651858.
28. Subcommittee on diagnosis and management of bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics 118 (2006) 1774-1793
29. Dawson K., Kennedy D., Asher I., Cooper D., Cooper P., Francis P., et al. Consensus view: the management of acute bronchiolitis. J Paediatr Child Health 29 (1993) 335-337
30. Patel H., Platt R., Lorenzo J.M., and Wang E.E.L. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database of Systematic Reviews (2004) issue 3. Art No: CD004878. DOI: DOI: 10.1002/14651858.
31. Garrison M.M., Christakis D.A., Harvey E., Cummings P., and Lavis R.L. Systemic corticosteroids in infant bronchiolitis: a meta-analysis. Pediatrics 105 (2000) e44
32. Blom D., Ermers M., Bont L., van Aaldren W.M.C., and van Woensel J.M.B. Inhaled corticosteroids during acute bronchiolitis in the prevention of post-bronchiolitis wheezing. Cochrane Database of Systematic Reviews (2007) issue 1. Art. No: CD004881. DOI: DOI: 10.1002/14651858.
33. Kuzik B.A., Al Qadhi S.A., Kent S., Flavin M.P., Hopman W., Hotte S., and Gander S. Nebulized hypertonic saline in the treatment of viral bronchiolitis in infants. J Pediatr 151 (2007) 266-270
34. Bye P.T.P., and Elkins M.R. Mini-symposium: airway clearance in cystic fibrosis. Other mucoactive agents for cystic fibrosis. Pediatr Respir Rev 8 (2007) 30-39
35. Mandelberg A., Tal G., Witzling M., Someck E., Houri S., Balin A., et al. Nebulized 3% hypertonic saline solution treatment in hospitalized infants with viral bronchiolitis. Chest 123 (2003) 481-487
36. Sarrell E.M., Tal G., Witzling M., Someck E., Houri S., Cohen H.A., et al. Nebulized 3% hypertonic saline solution treatment in ambulatory children with viral bronchiolitis decreases symptoms. Chest 122 (2002) 2015-2020